中国肿瘤临床2024,Vol.51Issue(15) :757-763.DOI:10.12354/j.issn.1000-8179.2024.20240784

阿片类药物不良反应综合防治专家共识(2024年版)

Expert consensus on integrated prevention and treatment of opioid-related adverse drug reactions(2024 edition)

中国抗癌协会肿瘤整体评估专业委员会 刘波
中国肿瘤临床2024,Vol.51Issue(15) :757-763.DOI:10.12354/j.issn.1000-8179.2024.20240784

阿片类药物不良反应综合防治专家共识(2024年版)

Expert consensus on integrated prevention and treatment of opioid-related adverse drug reactions(2024 edition)

中国抗癌协会肿瘤整体评估专业委员会 刘波
扫码查看

摘要

阿片类药物作为经典镇痛药在临床中被广泛应用,但其在使用过程中会产生多种不良反应.镇痛治疗中发生的这些不良反应会不同程度地影响患者的情绪、社交或日常活动,甚至影响患者镇痛药物的使用.本共识针对使用阿片类药物镇痛的癌痛患者人群,旨在为医务工作者在该人群治疗中出现的不良反应的防治提供指导.

Abstract

Data have shown that nearly 80%of patients with malignant tumors in China fail to receive effective control of cancer pain.Opioids,the classic analgesics,are commonly used in clinical practice for analgesia;however,they cause numerous adverse reactions.These adverse reactions during analgesic therapy can affect the patient's mood,social life,or daily activities to varying degrees,which con-sequently affect the continued use of analgesics.This consensus focuses on patients with cancer pain who are prescribed opioids for anal-gesia by healthcare providers and aims to suggest measures for the prevention and treatment of adverse reactions occurring during the opioid treatment.

关键词

阿片类药物/不良反应/防治/癌痛/专家共识

Key words

opioid drugs/adverse reactions/prevention and treatment/cancer pain/expert consensus

引用本文复制引用

出版年

2024
中国肿瘤临床
中国抗癌协会

中国肿瘤临床

CSTPCD北大核心
影响因子:1.32
ISSN:1000-8179
参考文献量6
段落导航相关论文